Treatment of stimulant use disorders: current practices and promising perspectives
ACKNOWLEDGEMENTS
This publication has been prepared by the United Nations Office on Drugs and Crime (UNODC), Drug Prevention and Health Branch (DHB), Prevention Treatment and Rehabilitation Section (PTRS), in the context of the global project Treatnet II. The aim is to encourage Member States to consider expanding treatment options in medical interventions for individuals affected by stimulant use disorders. The document underlines the urgent need to share information with the wider community of policy makers, health professionals involved in addiction medicine around the world.
UNODC would like to acknowledge the following persons for their important contributions to the process of publishing this document:
The Expert Group, consisting of Kristina Adorjan, Yamilka Lineth Sánchez Alvarado, Peter Blanken, Violeta Bogdanova, Warren Burnhams, Marco Diana, Colin Davidson, Ahamed Awad Abd Alrahmen Elgamel, Mohamed Ali Mohamed Elmahi, Nadine Ezard, José Antonio Fuentealba Evans, Ali Farhoudian, Gabriele Fischer, Clara H. Fuderanan, Carl Hart, Carlos Augusto Ordóñez Huamán, Nitya Jayaram-Lindström, Delfin P. Gubatan Jr., Vicknasingam Balasingam Kasinather, Andrej Kastelic, Riaz Khan, Ronaldo Ramon Laranjeira, Rebecca McKetin, Ľubomir Okruhlica, Plamen Popov, Katharina Schoett, Thomas G. Schulze, Nuša Šegrec, Svetlana Shakhova, Steven Shoptaw, Ayumi Tanako, Aviv Malkiel Weinstein, Lucas Wiessing, Apisak Wittayanookulluk, Marcin Wojnar. Adam Bisaga and Marek Chawarski, UNODC consultants, for the development of this document.
With thanks to the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and the following UNODC staff who contributed to the document (in alphabetical order): Anja Busse, Monica Beg, Giovanna Campello, Monica Ciupagea, Wataru Kashino, Kamran Niaz, Olga Parakkal, Elizabeth Saenz, Sanita Suhartono, Justice Tettey, under the supervision by Gilberto Gerra UNODC, DHB.
